Inositol (for PCOS)

Inositol refers to a family of sugar alcohols (cyclitols) that act as second messengers in insulin signaling. The two forms that matter clinically are myo-inositol (MI) and D-chiro-inositol (DCI). Both are present naturally in the body, in foods, and in supplements. Inositol has emerged over the past 15 years as one of the better-evidenced supplements for PCOS, particularly for the metabolic phenotype.

Consult a provider before starting supplements, especially if pregnant, breastfeeding, or on medications. PCOS management benefits from clinical oversight.

What the evidence says

The evidence base for inositol in PCOS is moderate to growing-strong:

  • Improved ovulation rates. Multiple randomized trials show myo-inositol increases ovulation frequency in PCOS users, particularly the insulin-resistant phenotype.
  • Improved insulin sensitivity. Reductions in fasting insulin and HOMA-IR are consistent across trials.
  • Reduced androgens. Modest reductions in total and free testosterone.
  • Better menstrual regularity. Trials show shorter cycle length variability and more frequent cycles.
  • Egg quality in IVF. Several trials in ART settings show improved oocyte and embryo quality with myo-inositol pretreatment.
  • Gestational diabetes prevention. Some evidence for reducing GDM risk in high-risk groups.

A 2018 Cochrane review described inositol as a promising treatment for PCOS, with caveats about heterogeneity in trials. The 2023 international PCOS guidelines list inositol as a complementary option with growing evidence.

The honest position: inositol is one of the better-supported PCOS supplements but is not a substitute for the lifestyle and medical interventions (resistance training, metformin where indicated, ovulation induction where appropriate).

Why it might work

Both forms act as second messengers in insulin signaling, but in different tissues:

  • Myo-inositol is the dominant form in most tissues and is converted to D-chiro-inositol locally as needed. In PCOS, conversion from MI to DCI appears altered, especially in ovarian tissue, where MI levels can be relatively deficient.
  • D-chiro-inositol is involved in glycogen storage and insulin signaling. Excess DCI in ovarian tissue may actually worsen oocyte quality, which is why the ratio between forms matters.

By restoring an appropriate physiological balance, inositol supplementation may improve ovarian insulin signaling and follicle maturation.

Dosing

The standard regimen with the most trial support: 4g myo-inositol + 100mg D-chiro-inositol daily (40:1 ratio), split into two doses.

A few things to know:

  1. The 40:1 ratio matters. It approximates the physiological ratio in plasma. Products at 1:1 or DCI-dominant ratios have less trial support and may not work as well, particularly for ovarian effects.
  2. Powder form dissolves well in water and is the standard delivery for the high gram-dose. Capsule forms exist but require many capsules.
  3. Continuous daily dosing. Effects build over 3 to 6 months. Trials typically run 3 to 12 months before assessing primary outcomes.
  4. Myo-inositol-only products (without DCI) also have evidence, particularly for ovulation. The 40:1 combination is the most-supported formulation but is not the only effective one.

Where to get it. For the 40:1 ratio used in most trials, look for myo-inositol + D-chiro inositol PCOS blend (Amazon). Powder form is the easiest way to hit the 4g myo-inositol dose without taking a dozen capsules.

Common side effects and cautions

Inositol is among the better-tolerated supplements for PCOS:

  • GI upset at higher doses (nausea, loose stools).
  • Headache rarely.
  • Hypoglycemia is theoretical but rare; relevant for users on diabetes medications.

Cautions:

  • Medication interactions. Discuss with a provider if on metformin, insulin, or other diabetes medications, given the overlapping mechanism.
  • Pregnancy. Inositol has been used safely in pregnancy in some trials (GDM prevention), but discuss with a provider before continuing during pregnancy.
  • Lithium. Theoretical interaction; consult a psychiatrist if relevant.

Where it fits

Inositol is a reasonable first-line supplement for PCOS, especially for users with insulin resistance, irregular cycles, or fertility goals. It is often paired with lifestyle interventions and, where indicated, metformin or ovulation induction.

It is not a substitute for clinical management of PCOS. Persistent absent ovulation, severe androgen excess, or fertility concerns warrant specialist care.

Related reading